ZC3H14 antibody
Principal name
ZC3H14 antibody
Alternative names for ZC3H14 antibody
NY-REN-37, Zinc finger CCCH domain-containing protein 14
SwissProt ID
Q08AZ1 (Xenla), Q3ZC82 (Bovin), Q5F3Z9 (Chick), Q6PJT7 (Human), Q7TMD5 (Rat), Q8BJ05 (Mouse)
Ncbi ID
9606, NP_997545, NP_001153575, NM_207662, NM_001160104, NP_001153575.1, NP_001008506.2, NM_001160107, NM_029334, NM_001008506, NM_001033951, NM_138920, NM_207660, NM_207661, NM_001160103
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB)
Background of ZC3H14 antibody
- Kit Component:
- - KN319641G1, Zc3h14 gRNA vector 1 in pCas-Guide vector
- KN319641G2, Zc3h14 gRNA vector 2 in pCas-Guide vector
- KN319641D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Kelly,S.M., (2007) Proc. Natl. Acad. Sci. U.S.A. 104 (30), 12306-12311
Immunofluorescence of purified MaxPab antibody to ZC3H14 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of FLJ11806 expression in transfected 293T cell line by FLJ11806 MaxPab polyclonal antibody.Lane 1: FLJ11806 transfected lysate(33.66 KDa).Lane 2: Non-transfected lysate.
Human Heart; WB Suggested Anti-ZC3H14 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human heart; ZC3H14 antibody - N-terminal region (ARP53850_P050) in Human Heart cells using Western Blot
ZC3H14 Antibody (Center) (AP54620PU-N) western blot analysis in T47D cell line lysates (35 µg/lane). This demonstrates the ZC3H14 antibody detected the ZC3H14 protein (arrow).
WB Suggested Anti-ZC3H14 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human heart
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP54620PU-N | ZC3H14 (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY403936 | ZC3H14 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY431585 | ZC3H14 overexpression lysate |
|
|
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR217782L2V | Lenti ORF particles, Zc3h14 (GFP-tagged) - Mouse zinc finger CCCH type containing 14 (Zc3h14), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,340.00
|
|
| OriGene Technologies, Inc. | ||
| MR209075L2V | Lenti ORF particles, Zc3h14 (GFP-tagged) - Mouse zinc finger CCCH type containing 14 (Zc3h14), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR216261L1V | Lenti ORF particles, Zc3h14 (Myc-DDK-tagged) - Mouse zinc finger CCCH type containing 14 (Zc3h14), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,360.00
|
|
| OriGene Technologies, Inc. | ||
| MR217782L1V | Lenti ORF particles, Zc3h14 (Myc-DDK-tagged) - Mouse zinc finger CCCH type containing 14 (Zc3h14), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,200.00
|
|
| OriGene Technologies, Inc. | ||
| MR209075L1V | Lenti ORF particles, Zc3h14 (Myc-DDK-tagged) - Mouse zinc finger CCCH type containing 14 (Zc3h14), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR200172L2V | Lenti ORF particles, Zc3h14 (GFP-tagged ORF) - Rat zinc finger CCCH type containing 14 (Zc3h14), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,520.00
|
|
| OriGene Technologies, Inc. | ||
| RR200173L2V | Lenti ORF particles, Zc3h14 (GFP-tagged ORF) - Rat zinc finger CCCH type containing 14 (Zc3h14), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,340.00
|
|
| OriGene Technologies, Inc. | ||
| RR200172L1V | Lenti ORF particles, Zc3h14 (Myc-DDK-tagged ORF) - Rat zinc finger CCCH type containing 14 (Zc3h14), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,360.00
|
|
| OriGene Technologies, Inc. | ||
| RR200173L1V | Lenti ORF particles, Zc3h14 (Myc-DDK-tagged ORF) - Rat zinc finger CCCH type containing 14 (Zc3h14), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,200.00
|
|
| OriGene Technologies, Inc. | ||